Training for ophthalmic use of strontium-90.
Except as provided in WAC
246-240-078, the licensee shall require the authorized user of strontium-90 for ophthalmic radiotherapy to be a physician who:
(1) Is an authorized user under WAC
246-240-278 or equivalent agreement state or NRC requirements; or
(2)(a) Has completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy. The training must include:
(i) Radiation physics and instrumentation;
(ii) Radiation protection;
(iii) Mathematics pertaining to the use and measurement of radioactivity; and
(iv) Radiation biology; and
(b) Supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user at a medical institution that includes the use of strontium-90 for the ophthalmic treatment of five individuals.
This supervised clinical training must involve:
(i) Examination of each individual to be treated;
(ii) Calculation of the dose to be administered;
(iii) Administration of the dose; and
(iv) Follow up and review of each individual's case history; and
(c) Has obtained written attestation, signed by a preceptor authorized user who meets the requirements in WAC
246-240-078,
246-240-278, 246-240-281, or equivalent agreement state or NRC requirements, that the individual has satisfactorily completed the requirements in (a) and (b) of this subsection and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use.
[Statutory Authority: RCW
70A.388.040 and
70A.388.110. WSR 22-19-084, § 246-240-281, filed 9/20/22, effective 10/21/22. Statutory Authority: RCW
70.98.050. WSR 13-11-021, § 246-240-281, filed 5/7/13, effective 6/7/13; WSR 11-03-068, § 246-240-281, filed 1/18/11, effective 2/18/11; WSR 06-05-019, § 246-240-281, filed 2/6/06, effective 3/9/06.]